CV Sciences, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
9530 PADGETT STREET, SAN DIEGO, CA, 92126
Mailing Address
9530 PADGETT STREET, SAN DIEGO, CA, 92126
Phone
866-290-2157
Fiscal Year End
1231
EIN
800944970
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 10-K Annual financial report | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
| 8-K Current report of material events | October 10, 2025 | View on SEC |
| 8-K Current report of material events | September 18, 2025 | View on SEC |
| 8-K Current report of material events | August 13, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 13, 2025 | View on SEC |
| 8-K Current report of material events | June 5, 2025 | View on SEC |
Annual Reports
10-K
March 26, 2026
- Successful turnaround strategy reducing net losses from $2.4M to $0.9M.
- Improved operational efficiency with gross profit margins rising to 49%.
Material Events
8-K
Financial Distress
March 10, 2026
High Impact
- Secured immediate cash flow relief by eliminating monthly debt payments.
- Successfully restructured existing debt with a major institutional investor.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.